Pfizer, Gates Foundation team up on low-cost injectable contraceptive

Pfizer ($PFE) inked a deal with the Bill & Melinda Gates Foundation to roll out a long-acting contraceptive in 69 of the world's poorest countries. The drug is a version of its injectable Depo-Provera, packaged in capsule syringes for easy transport and injection. The product will be sold for about $1 per dose, subsidized by the foundation and the U.S. government. Report (sub. req.)

Suggested Articles

Stephen Hahn, an oncologist who served as the chief medical officer for the MD Anderson Cancer Center, has secured Senate confirmation as FDA head.

As BMS searches for bright spots in its Opdivo-chemo combo fail from June, it’s zeroing in on squamous lung cancer patients who seemed to benefit.

The FDA's ad watchdog served its most serious violation to Alkermes Wednesday—and it took the unusual step of announcing that violation to the world.